Skip to content
Home/Companies/MedTech/Proteor
PR

Proteor

MedTech·France·Active·1yr hold

Proteor is a healthcare company, headquartered in France.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Proteor?

Proteor is currently owned by Eurazeo through Nov Sante Actions Non Cotees (2020 vintage), since 2025. Across its history, Proteor has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Eurazeo
Most recent investor
Eurazeo
Nov Sante Actions Non Cotees · 2020 · Healthcare
3 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

3 ownership periods · co-invest detected

Active
Co-held by BNP Paribas Developpement and Eurazeo since 2025.
Ardian
ArdianExited 2025
2021 · 2025 · Ardian Growth Fund II · 2018 · Growth
Secondary · to
MOIC
–
Co-invest · 2 holders · 2025 · present
BNP Paribas Developpement
BNP Paribas DeveloppementActive
2025 · present · BNP Paribas Developpement · 1991 · Growth
MOIC
–
Eurazeo
EurazeoActive
2025 · present · Nov Sante Actions Non Cotees · 2020 · Healthcare
MOIC
–

More from Nov Sante Actions Non Cotees

Other portfolio companies in the same fund.

Imapole
Active
MedTechFrance· 2023
Kinvent
Active
MedTechFrance· 2023
Horus Pharma
Active
HealthcareFrance· 2022
Oncodesign
Active
BiotechFrance· 2022
Groupe PSIH
Active
HealthTechFrance· 2021
Novair
Active
MedTechFrance· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Serres
Active
G Square Healthcare PEFinland· 2026
Stago
Active
ARCHIMEDFrance· 2026
Amoena
Active
Apera Asset ManagementGermany· 2025
Amotio
Active
Development Bank of WalesUK· 2025
Data refreshed weekly · Sourced from public filings